NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

4.5
(73)
Write Review
More
$ 21.00
Add to Cart
In stock
Description

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated

PDF) Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to

Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect

Vaccine - Wikipedia

Vaccine value profile for enterotoxigenic Escherichia coli (ETEC

Key roles of adjuvants in modern vaccines - Document - Gale

Frontiers Factors Which Contribute to the Immunogenicity of Non

Frontiers Progress and Pitfalls in the Quest for Effective SARS

Mucosal vaccines — fortifying the frontiers

Key roles of adjuvants in modern vaccines - Document - Gale

Frontiers CAvant® WO-60 as an Effective Immunological Adjuvant

Vaccine Adjuvant Clinical Evaluation

Salmonella enterica serovar Typhi live vector vaccines finally